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Modern contraceptive use in 
India has steadily increased, 
but remains heavily skewed 
towards female sterilization. 
Use of modern spacing methods 
such as injectables, the pill, 
and the IUCD is low, and 
discontinuation rates are high. 
Achieving the goal of expanding 
the method mix by increasing 
reliance on modern spacing 
methods, as laid out in India’s 
FP2020 commitment, requires 
understanding and addressing 
the reasons for discontinuation 
and for method switching (or 
non-switching), from both 
the user’s and the provider’s 
perspective. 
The use of modern contraceptive methods has steadily increased in 
India from 33% in 1992-93 (NFHS-1) to 48% in 2007-08 (DLHS-3). The 
method mix favors female sterilization, with close to 3 out of 4 (72%) 
married modern contraceptive users choosing female sterilization, 
followed by condoms (13%), pills (9%), IUCD (4%), and male sterilization 
(2%) (DLHS-3). As articulated in its FP2020 commitment, India is looking 
to expand its method mix to include a greater reliance on modern 
spacing methods and postpartum IUCDs. Discontinuation rates, however, 
remain high for modern spacing methods. The one-year contraceptive 
discontinuation rate for modern spacing methods is 42.3% (NFHS-3). 
Discontinuation rates are the highest for injectables (53.4%), followed 
by the pill (49.2%), condoms (44.8%) and the IUCD (19.8%). In only 1 
out of 10 (9.8%) discontinuation episodes did the family planning (FP) 
user switch to a different contraceptive method. In order to realize a 
goal of 48 million additional residents adopting FP by 2020 through 
an expanded contraceptive method mix, a better understanding 
of contraceptive use dynamics like factors that influence decision-
making around contraceptive choice, discontinuation, and switching is 
paramount to designing effective family planning programs that meet the 
needs of women and their families.
STUDY OBJECTIVES
The Evidence Project, in response to a request from USAID/India 
to explore contraceptive use dynamics among married women in 
India, proposes to conduct a cohort study with the following research 
objectives:
1. to assess one-year modern spacing contraceptive discontinuation 
rates by modern spacing methods (pill, IUCD/PPIUD, injectable) 
among a cohort of modern spacing contraceptive users
2. to measure influencing facilitators for contraceptive continuation 
and discontinuation, including intensity of experienced side effects
3. to measure the Method Information Index (MII) that measures 
client’s recall of counseling information received
4. to assess influencing factors that lead to contraceptive switching or 
non-switching
5. to explore providers’ attitudes about contraceptive discontinuation 
and switching, and their practices with clients who want to 
discontinue or switch
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METHODOLOGY
A cohort study of approximately 3,000 new spacing modern 
method users (pill, IUCD/postpartum IUD, and injectables) 
will be followed for one year. New users will be married, 
between the ages of 15-49 years old, and may or may not 
have used contraceptives previously. They will be interviewed 
at the time of method adoption and at three follow-up points: 
3 months, 6 months, and 1 year. 
The study will take place in three diverse states that will be 
selected in consultation with USAID/India and the Ministry 
of Health and Family Welfare (MOHFW). The study states will 
be selected from the states where Jhpiego, under the MCSP 
Project, is providing technical assistance to the MOHFW 
to expand the availability of contraceptives and improve 
the quality of services offered at select government health 
facilities. Those states include: Andhra Pradesh, Assam, 
Chhattisgarh, Maharashtra, and Orissa. Within each of the 
selected three states, recruitment of new IUCD/PPIUD and 
injectable users will occur at government health facilities 
that are receiving support from Jhpiego and that are not 
receiving support from Jhpiego. New pill user recruitment will 
take place through community health workers (ASHAs). 
DATA TO BE COLLECTED
An intensity of side effects scale will be developed and 
tested to further our understanding of how side effects 
impact different spheres of women’s lives (e.g. domestic, 
religious, sexual, social), and to determine at what point 
a side effect becomes intolerable, such that a woman 
chooses to discontinue its use. Likert-style questions will be 
developed to assess women’s experiences of side effects, 
and women will be asked to rate the intensity of side effects 
on a scale of 1 to 10. These measures will be assessed over 
time at the individual level, and used to predict subsequent 
contraceptive use and discontinuation. 
Data will also be collected on the Method Information 
Index, an index collected nationally by FP2020 and the DHS 
that measures the extent to which women were told about 
alternative methods and were given sufficient information 
about the alternative methods. The Index is based on three 
questions: 1) Were you told about family planning methods 
other than the one you selected today?; 2) Were you told 
today about side effects or problems you might have with the 
selected method?; and 3) Were you told today what to do if 
you experience side effects? 
Given the CPR and TFR trends reported recently in the 
NFHS-4 in several states, data will be collected to explore 
knowledge, attitudes and use of emergency contraceptive 
pills (ECP) since the last birth interval. These data will be 
collected in the enrollment and follow-up surveys to assess 
changes in ECP awareness and use over time. 
In addition, in-depth interviews will be conducted with a 
subsample of respondents who discontinue use of a modern 
spacing method and a subsample who switch to a different 
method during the one-year follow-up period, to further 
understand the social and contextual issues that lead to 
these behaviors. 
On the supply side, surveys will be conducted with providers 
to assess their knowledge of medical practices related 
to safe procedures of starting a new FP method while 
discontinuing a different FP method, attitudes towards 
clients who seek counseling related to side effects and who 
may wish to discontinue a method, and provider practices 
when clients seek to discontinue a method, including 
whether providers counsel clients on method switching and 
if so, switching to which method and why. Facility audits 
will also be conducted at each facility where respondents 
are recruited to ascertain the availability of contraceptive 
methods, as this influences a user’s ability to switch 
methods. 
RESEARCH UTILIZATION
The study will be supported by a strong research utilization 
(RU) strategy that begins with the designation of study 
advisory committee (SAC) members who will meet 
biannually. Members of the SAC will include Ministry 
of Health and Family Welfare, donors like USAID, The 
David & Lucile Packard Foundation, DFID and The Bill & 
Melinda Gates Foundation, in addition to technical and 
implementing partners in India, including Jhpiego, IPPF, 
EngenderHealth and MSI. The SAC will meet to review the 
study design, discuss preliminary findings, and participate in 
interpretation of study findings. With the SAC, programmatic 
recommendations will be determined and briefs, in addition 
to other materials, will be developed for widespread 
dissemination. 
For more information contact Kumudha Aruldas at akumudha@popcouncil.org or Aparna Jain at apjain@popcouncil.org
The Evidence Project is led by the Population Council in 
partnership with INDEPTH Network, International Planned 
Parenthood Federation, Management Sciences for Health, 
PATH, Population Reference Bureau, and a University Re-
search Network. Other partners are FHI360, Meridian 
Group International, Inc., and What Works Association. 
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